As of 2025-04-24, the Relative Valuation of TCR2 Therapeutics Inc (TCRR) is (58.16) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.48 USD, the upside of TCR2 Therapeutics Inc based on Relative Valuation is -4029.6%.
The range of the Relative Valuation is (36.31) - (84.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 23.3x | 14.5x |
| Forward P/E multiples | 8.1x - 20.3x | 13.5x |
| Fair Price | (36.31) - (84.50) | (58.16) |
| Upside | -2553.2% - -5809.1% | -4029.6% |
| Date | P/E |